SCHEMBL4182928

SCHEMBL4182928

COc1ccc(C=C(C#N)S(=O)(=O)Cc2ccccc2)c(F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
POLB P06746 2/20 0.46
MAPT P10636 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
ALDH1A1 P00352 3/20 0.45
MAPK1 P28482 1/20 0.45
PTK2B Q14289 1/20 0.45
LMNA P02545 2/20 0.43
SLC16A3 O15427 1/20 0.41
SLC16A1 P53985 1/20 0.41
KDM4E B2RXH2 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40
CYP1A1 P04798 1/20 0.40
CYP1B1 Q16678 1/20 0.40
HTT P42858 1/20 0.40
HPGD P15428 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4182922 1.00 MEN1 (0.46) MEN1KMT2APOLBMAPTNPSR1
SCHEMBL4182926 1.00 MEN1 (0.46) MEN1KMT2APOLBMAPTNPSR1
SCHEMBL4185329 0.90 EGFR (0.41) MEN1KMT2APOLBMAPTNPSR1
SCHEMBL4185320 0.90 EGFR (0.41) MEN1KMT2APOLBMAPTNPSR1
SCHEMBL4185324 0.90 EGFR (0.41) MEN1KMT2APOLBMAPTNPSR1
SCHEMBL4176474 0.88 ALDH1A1 (0.51) MEN1KMT2APOLBMAPTNPSR1
SCHEMBL4191978 0.88 LMNA (0.48) MEN1KMT2APOLBMAPTNPSR1
SCHEMBL4176478 0.88 ALDH1A1 (0.51) MEN1KMT2APOLBMAPTNPSR1
SCHEMBL4191982 0.88 LMNA (0.48) MEN1KMT2APOLBMAPTNPSR1
SCHEMBL4176471 0.88 ALDH1A1 (0.51) MEN1KMT2APOLBMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-07-30 US claimed
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090191193-A1 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof ARSA, STS, SULT2A1 MEN1 2503/4885KMT2A 469/4885POLB 3367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.